{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T22:31:12Z","timestamp":1778452272728,"version":"3.51.4"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1007\/s10620-009-0988-9","type":"journal-article","created":{"date-parts":[[2009,9,30]],"date-time":"2009-09-30T21:36:43Z","timestamp":1254346603000},"page":"2086-2088","source":"Crossref","is-referenced-by-count":28,"title":["Statins in Primary Biliary Cirrhosis: Are They Safe?"],"prefix":"10.1007","volume":"55","author":[{"given":"Murad Abu","family":"Rajab","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marshall M.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,10,1]]},"reference":[{"key":"988_CR1","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","volume":"353","author":"MM Kaplan","year":"2005","unstructured":"Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med. 2005;353:1261\u20131273.","journal-title":"N Engl J Med"},{"key":"988_CR2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/gut.51.2.265","volume":"51","author":"M Longo","year":"2002","unstructured":"Longo M, Crosignani A, Battezzati PM, et\u00a0al. Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis. Gut. 2002;51:265\u2013269.","journal-title":"Gut"},{"key":"988_CR3","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1053\/j.gastro.2004.02.015","volume":"126","author":"N Chalasani","year":"2004","unstructured":"Chalasani N, Aljadhey H, Kesterson J, Murray MD, Hall SD. Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity. Gastroenterology. 2004;126:1287\u20131292.","journal-title":"Gastroenterology"},{"key":"988_CR4","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.cgh.2006.04.020","volume":"4","author":"R Vuppalanchi","year":"2006","unstructured":"Vuppalanchi R, Chalasani N. Statins for hyperlipidemia in patients with chronic liver disease: are they safe? Clin Gastroenterol Hepatol. 2006;4:838\u2013839.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"988_CR5","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.cgh.2006.03.014","volume":"4","author":"S Khorashadi","year":"2006","unstructured":"Khorashadi S, Hasson NK, Cheung RC. Incidence of statin hepatotoxicity in patients with hepatitis C. Clin Gastroenterol Hepatol. 2006;4:902\u2013907.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"988_CR6","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1007\/s10620-007-0003-2","volume":"53","author":"CM Stanca","year":"2008","unstructured":"Stanca CM, Bach N, Allina J, Bodian C, Bodenheimer H Jr, Odin JA. Atorvastatin does not improve liver biochemistries or Mayo Risk Score in primary biliary cirrhosis. Dig Dis Sci. 2008;53:1988\u20131993.","journal-title":"Dig Dis Sci"},{"key":"988_CR7","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/hep.21741","volume":"46","author":"T Stojakovic","year":"2007","unstructured":"Stojakovic T, Putz-Bankuti C, Fauler G, et\u00a0al. Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid. Hepatology. 2007;46:776\u2013784.","journal-title":"Hepatology"},{"key":"988_CR8","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0168-8278(02)00006-5","volume":"36","author":"U Ritzel","year":"2002","unstructured":"Ritzel U, Leonhardt U, Nather M, Schafer G, Armstrong VW, Ramadori G. Simvastatin in primary biliary cirrhosis: effects on serum lipids and distinct disease markers. J Hepatol. 2002;36:454\u2013458.","journal-title":"J Hepatol"},{"key":"988_CR9","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/hep.21848","volume":"46","author":"JH Lewis","year":"2007","unstructured":"Lewis JH, Mortensen ME, Zweig S, et\u00a0al. Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial. Hepatology. 2007;46:1453\u20131463.","journal-title":"Hepatology"},{"key":"988_CR10","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1592\/phco.28.9.1188","volume":"28","author":"S Tuteja","year":"2008","unstructured":"Tuteja S, Pyrsopoulos NT, Wolowich WR, et\u00a0al. Simvastatin-ezetimibe-induced hepatic failure necessitating liver transplantation. Pharmacotherapy. 2008;28:1188\u20131193.","journal-title":"Pharmacotherapy"},{"key":"988_CR11","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/0016-5085(85)90642-0","volume":"89","author":"CE Jahn","year":"1985","unstructured":"Jahn CE, Schaefer EJ, Taam LA, et\u00a0al. Lipoprotein abnormalities in primary biliary cirrhosis. Association with hepatic lipase inhibition as well as altered cholesterol esterification. Gastroenterology. 1985;89:1266\u20131278.","journal-title":"Gastroenterology"},{"key":"988_CR12","doi-asserted-by":"crossref","first-page":"31B","DOI":"10.1016\/0002-9149(90)90438-7","volume":"66","author":"SM Grundy","year":"1990","unstructured":"Grundy SM, Vega GL, Garg A. Use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in various forms of dyslipidemia. Am J Cardiol. 1990;66:31B\u201338B.","journal-title":"Am J Cardiol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-009-0988-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-009-0988-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-009-0988-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T19:42:52Z","timestamp":1559245372000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-009-0988-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,1]]},"references-count":12,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["988"],"URL":"https:\/\/doi.org\/10.1007\/s10620-009-0988-9","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,1]]}}}